How to overcome the disturbing effects of human anti-mouse antibodies (HAMA) on in vitro assays

Int J Biol Markers. 1997 Jan-Mar;12(1):15-7. doi: 10.1177/172460089701200103.

Abstract

The development of human anti-mouse antibodies (HAMA) is a common immune response in patients with ovarian carcinoma after repeated injections of murine anti-CA 125 monoclonal antibodies for immunoscintigraphy. As a tumor marker with significant diagnostic value CA 125 is routinely measured in the follow-up of tumor patients by immunoradiometric assays (IRMA) based on murine anti-CA 125 monoclonal antibodies. HAMA may cause false-positive findings in a CA 125-IRMA. In this report our group demonstrates a simple way of eliminating HAMA by protein A/G affinity chromatography allowing the reliable detection of the tumor marker CA 125 in the serum of patients with ovarian carcinoma.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antibodies, Anti-Idiotypic / blood
  • Antibodies, Anti-Idiotypic / chemistry
  • Antibodies, Anti-Idiotypic / immunology*
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Neoplasm / blood
  • Antibodies, Neoplasm / chemistry
  • Antibodies, Neoplasm / immunology*
  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / immunology*
  • Biomarkers, Tumor / therapeutic use
  • CA-125 Antigen / analysis*
  • CA-125 Antigen / immunology*
  • CA-125 Antigen / therapeutic use
  • Chromatography, Affinity
  • False Positive Reactions
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoradiometric Assay / methods
  • Mice
  • Ovarian Neoplasms / blood
  • Ovarian Neoplasms / immunology*
  • Ovarian Neoplasms / therapy

Substances

  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Neoplasm
  • Biomarkers, Tumor
  • CA-125 Antigen